Copyright © 2003 by the European Society of Cardiology.
Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulationin Cardiomyopathies) trial
a The Echocardiography Department, The Royal Brompton Hospital, Sydney Street,London SW3 6NP, UK
b Centre Cardio-Pneumologique, CHU, Rennes, France
Received May 31, 2002;
revised July 9, 2002;
accepted July 10, 2002
* Corresponding author. Tel.: +44-207-351-8209; fax: +44-207-351-8604
E-mail address: a.duncan{at}ic.ac.uk
Aims To use echocardiography to determine early and late haemodynamic effects of atrio-biventricular (A-BiV) pacing on left ventricular (LV) function and their interrelations with exercise tolerance.
Methods Thirty-four patients with ejection fraction <35% (18 idiopathic dilated cardiomyopathy (DCM) and 16 ischaemic cardiomyopathy, in sinus rhythm and with intra-ventricular conduction delay (IVCD)) were implanted with transvenous A-BiV pacemakers. Echocardiographic measurements were compared before implantation, after 3 months A-BiV pacing, and 3 months inactive pacing (ventricular inhibited pacing at 40beatsmin–1as part of a crossover design, and at 9- and 12-month longitudinal follow-up.
Results Total isovolumic time (IVT) halved after 3 months A-BiV pacing (from 20.1±4.4 to 10.7±4.9smin–1, 
) and did not change thereafter. LV cavity size fell after 3 months (end-diastolic dimension (EDD) 7.3±0.8 to 6.8±0.8cm, , and end-systolic dimension (ESD) 6.2±0.8 to 5.9±0.8cm, 
), with a further fall in EDD and ESD (by 8.4±7.8 and 8.8±7.8mm, respectively, both ) after 12 months. Although not a primary end-point of the study, the 12-month reduction in LVEDD and LVESD was greater in idiopathic DCM (by 8.9 and 9.8mm, 
, respectively) compared with ischaemic cardiomyopathy. The 6-min walk rose by 15% () and peak VO2by 10% 
after 3 months, with no further increase by 12 months, and no difference between idiopathic DCM and ischaemic cardiomyopathy. The increase in peak VO2at 12 months correlated with the fall in ESD (
, 
).
Conclusions A-BiV pacing shortens total IVT, reduces LV cavity size, and increases exercise tolerance in patients with DCM and IVCD. Ischaemic cardiomyopathy does not affect the exercise response, although it does reduce the extent of reverse remodelling.
Key Words: Atrio-biventricular • Pacing • Dilated cardiomyopathy • Intra-ventricular conduction delay • Total isovolumic time • Ventricular asynchrony
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Multi-chamber pacing: a perfect solution for cardiac mechanical dyssynchrony?
- John G.F. Cleland, Justin Ghosh, Nasrin K. Khan, Stefano Ghio, Luigi Tavazzi, and Gerry Kaye
EHJ 2003 24: 384-390.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  N. M. Hawkins, M. C. Petrie, M. I. Burgess, and J. J.V. McMurray Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1944 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ghio, N. Freemantle, L. Scelsi, A. Serio, G. Magrini, M. Pasotti, A. Shankar, J. G.F. Cleland, and L. Tavazzi Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial Eur J Heart Fail, May 1, 2009; 11(5): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Kwon, C. M. Halley, T. P. Carrigan, V. Zysek, Z. B. Popovic, R. Setser, P. Schoenhagen, R. C. Starling, S. D. Flamm, and M. Y. Desai Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 34 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Koniari, S. Gkizas, and E. Apostolakis eComment: Does cardiac resynchronisation therapy improve survival andquality of life in patients with end-stage heart failure? Interactive CardioVascular and Thoracic Surgery, December 1, 2008; 7(6): 1146 - 1147. [Full Text] [PDF]
|
|
|
|
 |
|
 R Chung, R Sutton, and M Y Henein Beyond dyssynchrony in cardiac resynchronisation therapy Heart, August 1, 2008; 94(8): 991 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H.M. Jansen, F. Bracke, J. m. van Dantzig, K. H. Peels, J. C. Post, H. C.M. van den Bosch, B. van Gelder, A. Meijer, H. H.M. Korsten, J. de Vries, et al. The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapy Eur J Echocardiogr, July 1, 2008; 9(4): 483 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Garcia-Bolao, B. Lopez, A. Macias, J. J. Gavira, P. Azcarate, and J. Diez Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy Eur. Heart J., April 1, 2008; 29(7): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Uebing, D. G. Gibson, S. V. Babu-Narayan, G. P. Diller, K. Dimopoulos, O. Goktekin, M. S. Spence, K. Andersen, M. Y. Henein, M. A. Gatzoulis, et al. Right Ventricular Mechanics and QRS Duration in Patients With Repaired Tetralogy of Fallot: Implications of Infundibular Disease Circulation, October 2, 2007; 116(14): 1532 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tumkosit, C. G. Martin, E. Bayram, T. M. Morgan, K. S. Lane, P. Rerkpattanapipat, C. A. Hamilton, K. M. Link, and W. G. Hundley Left Ventricular Spherical Remodeling and Apical Myocardial Relaxation: Cardiovascular MR Imaging Measurement of Myocardial Segments Radiology, August 1, 2007; 244(2): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Fruhwald, A. Fahrleitner-Pammer, R. Berger, F. Leyva, N. Freemantle, E. Erdmann, D. Gras, L. Kappenberger, L. Tavazzi, J.-C. Daubert, et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony Eur. Heart J., July 1, 2007; 28(13): 1592 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Donal, N. Vignat, C. De Place, E. Leray, C. Crocq, P. Mabo, J.-C. Daubert, and C. Leclercq Acute effects of biventricular pacing on right ventricular function assessed by tissue Doppler imaging Europace, February 1, 2007; 9(2): 108 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lipiecki, N. Durel, and J. Ponsonnaille Which patients with ischaemic heart disease could benefit from cell replacement therapy? Eur. Heart J. Suppl., December 1, 2006; 8(suppl_H): H3 - H7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. White, R. Yee, X. Yuan, A. Krahn, A. Skanes, M. Parker, G. Klein, and M. Drangova Delayed Enhancement Magnetic Resonance Imaging Predicts Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Dyssynchrony J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1953 - 1960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rivero-Ayerza, D. A.M.J. Theuns, H. M. Garcia-Garcia, E. Boersma, M. Simoons, and L. J. Jordaens Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur. Heart J., November 2, 2006; 27(22): 2682 - 2688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Duncan, E. Lim, J. Clague, D. G. Gibson, and M. Y. Henein Comparison of segmental and global markers of dyssynchrony in predicting clinical response to cardiac resynchronization Eur. Heart J., October 2, 2006; 27(20): 2426 - 2432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Schlosshan, D. Barker, C. Pepper, G. Williams, C. Morley, and L.-B. Tan CRT improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac flow- and pressure-generating capacity Eur J Heart Fail, August 1, 2006; 8(5): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hawkins, M. C. Petrie, M. R. MacDonald, K. J. Hogg, and J. J.V. McMurray Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? Eur. Heart J., June 1, 2006; 27(11): 1270 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Donal, C. Leclercq, C. Linde, and J.-C. Daubert Effects of cardiac resynchronization therapy on disease progression in chronic heart failure Eur. Heart J., May 1, 2006; 27(9): 1018 - 1025. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Kies, C Leclercq, G B Bleeker, C Crocq, S G Molhoek, C Poulain, L van Erven, M Bootsma, K Zeppenfeld, E E van der Wall, et al. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm Heart, April 1, 2006; 92(4): 490 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. St John Sutton, T. Plappert, K. E. Hilpisch, W. T. Abraham, D. L. Hayes, and E. Chinchoy Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Circulation, January 17, 2006; 113(2): 266 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kashani and S. S. Barold Significance of QRS Complex Duration in Patients With Heart Failure J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2183 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pieske Reverse remodeling in heart failure - fact or fiction? Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D66 - D78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Duncan, D. P. Francis, D. G. Gibson, and M. Y. Henein Limitation of exercise tolerance in chronic heart failure: distinct effects of left Bundle-Branch block and coronary artery disease J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1524 - 1531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Limacher Understanding the impact of abnormal cardiac activation on cardiac function J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1532 - 1533. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sciagra, M. Giaccardi, M. C. Porciani, A. Colella, A. Michelucci, P. Pieragnoli, G. Gensini, A. Pupi, and L. Padeletti Myocardial Perfusion Imaging Using Gated SPECT in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy J. Nucl. Med., February 1, 2004; 45(2): 164 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Linde Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure Heart, February 1, 2004; 90(2): 231 - 234. [Full Text] [PDF]
|
|